Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.82 EUR | +2.97% | +12.44% | -27.41% |
04-23 | Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 |
Business Summary
Number of employees: 509
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology
99.2
%
| 191 | 97.4 % | 157 | 99.2 % | -17.96% |
Diagnostics
0.8
%
| 5 | 2.6 % | 1 | 0.8 % | -76.79% |
RNAi
0.1
%
| 0 | 0.0 % | 0 | 0.1 % | +290.32% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Ireland
47.6
%
| 87 | 44.2 % | 75 | 47.6 % | -13.17% |
France
19.0
%
| 17 | 8.9 % | 30 | 19.0 % | +72.54% |
Other
8.6
%
| 13 | 6.7 % | 14 | 8.6 % | +4.17% |
United States
7.9
%
| 13 | 6.8 % | 13 | 7.9 % | -6.40% |
Rest of the European Union
6.9
%
| 19 | 9.6 % | 11 | 6.9 % | -42.40% |
Spain
4.4
%
| 17 | 8.5 % | 7 | 4.4 % | -58.36% |
Germany
2.9
%
| 15 | 7.6 % | 5 | 2.9 % | -69.05% |
Italy
2.6
%
| 15 | 7.7 % | 4 | 2.6 % | -72.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 29/04/86 | |
Director of Finance/CFO | - | 31/12/87 | |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 31/12/02 | |
Compliance Officer | - | 31/03/20 | |
Ali Zeaiter
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/12/17 |
Chief Tech/Sci/R&D Officer | - | 31/12/96 | |
Nadia Badri
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/10 |
Investor Relations Contact | - | 31/12/14 | |
Sales & Marketing | - | 29/02/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 29/04/86 | |
Director/Board Member | - | 29/04/86 | |
Director/Board Member | - | - | |
Director/Board Member | 79 | - | |
Director/Board Member | 78 | - | |
Director/Board Member | - | 24/06/19 | |
Director/Board Member | - | 28/06/22 | |
Mera Ortega
BRD | Director/Board Member | - | - |
Director/Board Member | - | 28/06/22 | |
Director/Board Member | - | 20/12/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,354,907 | 13,713,346 ( 74.71 %) | 715,000 ( 3.895 %) | 74.71 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
PHARMA MAR, S.A. 3.52% | 652,235 | 3.52% | 20,244,853 $ |
Company contact information
Pharma Mar SA
Avenida de los Reyes, 1 Polígono Industrial La Mina
28770, Colmenar Viejo
+34 91 846 60 00
http://www.pharmamar.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.41% | 545M | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-14.82% | 15.36B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- PHM Stock
- Company Pharma Mar, S.A.